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Abstract
Background: Fetal Alcohol Spectrum Disorder (FASD) remains a global public health problem. South Africa is
estimated to have the highest recorded prevalence of FASD. However, no study has systematically evaluated the
available prevalence studies to provide estimates that may facilitate effective planning and delivery of prevention
and management services. Therefore, we propose to conduct a systematic review and meta-analysis to report a
pooled estimate of the FASD prevalence among children, youth and adults in South Africa.
Methods: We will include quantitative (cohort and cross-sectional) studies that reported on the prevalence of FASD
in South Africa. We will search databases such as Academic Search Complete, Education Resource Information
Center (ERIC), SocINDEX, Health Source: Nursing/Academic Edition, Cumulative Index of Nursing and Allied Health
and PsycARTICLES), Scopus, Science Direct, Springer Link, JSTOR, SAGE journals, PubMed, Web of Science and
Sabinet. The references of included studies will be searched for additional studies on the prevalence of FASD. The
search will be from inception to October 2021. Screening of (titles, abstracts and full text of the potentially relevant
articles) will be done by two independent authors using software. All disagreements will be resolved by discussion.
A standardised data extraction form will be designed for the extraction. Two authors will independently extract the
data from the selected articles and all disagreements will be resolved by discussion. We will use a tool developed
by Munn and colleagues to critically appraise all the included studies. The primary outcome will be the proportion
of individuals with FASD in South Africa. We will use the Freeman–Tukey double arcsine transformation to
transform the raw prevalence estimates so that the data can follow an approximately normal distribution. We will
use random-effects models to calculate 95% confidence intervals and prediction intervals based on multiple meta-
analyses with transformed proportions. We will test heterogeneity using Cochran’s Q and describe using the I2
statistic.
Discussion: The pooled prevalence estimate will assist the government and other stakeholders (such as non-profit
organisations and researchers) to plan and prioritise prevention and management interventions.
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Background
Alcohol is identified as the primary cause of preventable
birth defects and developmental disorders [1]. Alcohol
consumption during pregnancy may lead to an array of
disorders collectively known as Fetal Alcohol Spectrum
Disorder (FASD) [2–4]. To be diagnosed with any of the
FASD (Fetal Alcohol Syndrome {FAS}, Partial FAS,
{PFAS}, Alcohol-Related Neurodevelopmental Disorder
{ARND}, and Alcohol-Related Birth Defects {ARBD}), an
individual must meet all or some of the following criteria
[2–4]. These criteria comprise documented prenatal al-
cohol exposure, pre-and post-natal growth deficiency,
deficient brain growth and neurobehavioral impairment
– with or without cognitive impairment [2–4]. In
addition to the above-mentioned diagnostic terms, “Neu-
robehavioral Disorder Associated with Prenatal Alcohol
Exposure” (ND-PAE) has been proposed and included in
the 2013 Diagnostic and Statistical Manual for Mental
Health Disorders (DSM-5) [5–8].
According to the World Health Organization, South
Africa has one of the highest reported per capita rates of
alcohol consumption in the world among those who do
consume alcohol [9]. It is widely held that heavy drink-
ing among poorer South Africans is deeply rooted in the
legacy of the ‘dop’ system, whereby alcoholic beverages
were offered to farmworkers as part of their wages [10].
Alcohol consumption during pregnancy is also wide-
spread in South Africa at a rate ranging from 2.5 to 45%
as reported in a review of alcohol exposure among preg-
nant women in sub-Saharan Africa [11]. An estimated
36.9% of women consume alcohol during pregnancy or
in the last 3 months before they become aware of their
pregnancy in a study conducted in the Western Cape
Province [12].
One in every 13 alcohol-exposed pregnancies results in
a FASD [13]. Globally, about 630,000 children are born
with FASD each year [13]. The global prevalence of FASD
was estimated to be 8 per 1000 children and youth in
2017 [13]. The prevalence of FASD varies from one coun-
try to another and in most countries, it has only been esti-
mated among sub-groups of the general population. For
example, in Canada, the prevalence of FASD was esti-
mated to be 18.1 per 1000 children in 2019 [14]. In 2018,
the prevalence of FASD was reported to range from 11.3
to 50.0 per 1000 children in the United States of America
(USA) [15]. In Australia, the prevalence of FASD was to
be 194.4 per 1000 children in 2017 [16].
According to the Foundation for Alcohol Related Re-
search (FARR), about 6 million individuals are affected
by FASD in South Africa [17]. In a prevalence study
conducted in some selected provinces of South Africa,
the prevalence of FASD was estimated to range from 29
to 290 per 1000 live births in 2016 [18]. The prevalence
of FASD varies from one province to another within
South Africa. In 2017, the prevalence of FASD among
grade one pupils in the Western Cape was estimated to
be 196 to 276 per 1000, the highest recorded prevalence
in any part of the world [19]. In the Northern Cape, the
prevalence was estimated at 63.9 per 1000 grade one pu-
pils in 2015 [20].
Prevalence studies have been conducted in South
Africa, however, most of the studies have been con-
ducted among subgroups of the general population
and in certain provinces. The evidence obtained from
these prevalence studies at best informs provincial
and regional policies and interventions. A pooled esti-
mate of FASD prevalence will provide robust evidence
to plan FASD-related prevention, treatment and man-
agement services at the national level through the de-
sign and implementation of national policy, which are
currently non-existing [21].
This proposed systematic review with meta-analysis
will paint a better picture of the problem of FASD in
South Africa. In addition, the result of the review will
provide information that may be used to lobby policy-
makers for the prioritisation of the FASD issues (which
is currently limited) in policies and interventions. More-
over, the pooled estimate will facilitate an accurate com-
parison of the prevalence of FASD in South Africa to
other countries. Therefore, we propose to conduct a sys-
tematic review and meta-analysis to report a pooled esti-
mate of the FASD prevalence in South Africa.
Research question
What is the pooled prevalence of FASD among children,
youth and adults in the general population in South
Africa?
Methods
In reporting this study, we will follow the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses Protocols (PRISMA-P) checklist [22] and
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) reporting guidelines [23]. This protocol has
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been registered in the International Prospective Register
of Systematic Reviews (PROSPERO) database (registra-
tion number: CRD42020197979).
Search strategy
We will search databases such as Academic Search
Complete, Education Resource Information Center (ERIC),
SocINDEX, Health Source: Nursing/Academic Edition, Cu-
mulative Index of Nursing and Allied Health, PsycARTI-
CLES, Scopus, Science Direct, Springer Link, JSTOR, SAGE
journals, PubMed and Sabinet. The grey literature will also
be searched. The references of included studies will be
searched for additional studies on the prevalence of FASD.
In addition, experts in the field will be contacted for recent
studies. The search will be from inception (January 1973,
when FAS was first described) to October 2021.
Search terms
The search terms will include Fetal Alcohol Spectrum
Disorders or Fetal Alcohol Syndrome or Partial Fetal
Alcohol Syndrome or Alcohol-Related Birth Defects
or Alcohol-Related Neurodevelopment Disorder or
Fetal Alcohol Effects (FAE) or Prenatal Alcohol Ex-
posure (PAE) or Neurobehavioral Disorder Associated
with Prenatal Alcohol Exposure (ND-PAE) and epi-
demiology or frequency or incidence or prevalence
and South Africa. We will combine the search terms
in various forms for the selected databases using
Boolean operators. The search will be done by one of
the authors with the assistance of a University librar-
ian and the second author will check the results of
the search for accuracy. Both authors have expertise
in conducting systematic reviews and meta-analyses.
The combination of search terms for one of the data-
bases is presented in Table 1 below.
Eligibility criteria
Studies will be considered for eligibility based on the fol-
lowing criteria.
Type of population/participants
We will include studies that recruited children, youth
and adults. In addition to the above, studies must in-
clude population and participants from South Africa.
We will not place any restrictions on the age of partici-
pants. Studies with individuals without FASD and those
from other countries will be excluded. Also, all animal
studies will be excluded.
Types of outcomes
The outcome is the proportion of individuals with FASD
(FAS, PFAS, ARND and ARBD) per thousand. Studies
will be included whether or not an outcome of interest




- F*tal alcohol spectrum disorder or FASD AND
Prevalence AND South Africa
- F*tal alcohol syndrome or FASD AND Prevalence AND
South Africa
- Partial f*tal alcohol syndrome or PFAS AND Prevalence
AND South Africa
- Prenatal alcohol exposure or pre-natal alcohol exposure
or PAE AND Prevalence AND South Africa
- Neurobehavioral disorder associated with prenatal
alcohol exposure or ND-PAE AND Prevalence AND
South Africa
- Alcohol related neurodevelopmental disorder or ARND
AND Prevalence AND South Africa




- F*tal alcohol spectrum disorder or FASD AND
Epidemiology AND South Africa
- F*tal alcohol syndrome or FASD AND Epidemiology
AND South Africa
- Partial f*tal alcohol syndrome or PFAS AND
Epidemiology AND South Africa
- Prenatal alcohol exposure or pre-natal alcohol exposure
or PAE AND Epidemiology AND South Africa
- Neurobehavioral disorder associated with prenatal
alcohol exposure or ND-PAE AND Epidemiology AND
South Africa
- Alcohol related neurodevelopmental disorder or ARND
AND Epidemiology AND South Africa
- F*tal alcohol effect or FAE AND Epidemiology AND
South Africa
(3) Frequency - F*tal alcohol spectrum disorder or FASD AND
Frequency AND South Africa
- F*tal alcohol syndrome or FASD AND Frequency AND
South Africa
- Partial f*tal alcohol syndrome or PFAS AND Frequency
AND South Africa
- Prenatal alcohol exposure or pre-natal alcohol exposure
or PAE AND Frequency AND South Africa
- Neurobehavioral disorder associated with prenatal
alcohol exposure or ND-PAE AND Frequency AND
South Africa
- Alcohol related neurodevelopmental disorder or ARND
AND Frequency AND South Africa
- F*tal alcohol effect or FAE AND Frequency AND South
Africa
(4) Incidence - F*tal alcohol spectrum disorder or FASD AND
Incidence AND South Africa
- F*tal alcohol syndrome or FASD AND Incidence AND
South Africa
- Partial f*tal alcohol syndrome or PFAS AND Incidence
AND South Africa
- Prenatal alcohol exposure or pre-natal alcohol exposure
or PAE AND Incidence AND South Africa
- Neurobehavioral disorder associated with prenatal
alcohol exposure or ND-PAE AND Incidence AND South
Africa
- Alcohol related neurodevelopmental disorder or ARND
AND Incidence AND South Africa
- F*tal alcohol effect or FAE AND Incidence AND South
Africa
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is reported as a primary or secondary outcome in the
original article.
Type of studies/study designs
We will include quantitative (cohort {prospective and
retrospective} and cross-sectional) studies that reported
on the prevalence of FASD (FAS, PFAS, ARND and
ARBD) in South Africa. We will include studies if they
(1) comprised of original research that estimated the
prevalence of FASD; (2) presented the results of primary
data; (3) are published in peer-reviewed journals; (4)
written in the English language; (5) provided the preva-
lence of FASD with a measure of uncertainty or the ne-
cessary information to calculate uncertainty (such as
sample size or the number of cases); (6) specified the
diagnostic guideline or case definition used for the esti-
mate of the prevalence and (7) used active case ascer-
tainment (searching for individuals with FASD in
selected populations), clinic-based methods (estimation
of FASD prevalence based on populations seen in hospi-
tals or clinics) and passive surveillance (estimation of
FASD prevalence via existing records and registries). We
will exclude studies if they (1) consisted of reviews
(scoping, systematic, narrative and rapid) and (2) re-
ported a pooled estimate by combining several studies.
Screening of studies
The screening will be done based on our eligibility cri-
teria set at the beginning of the current study. The
screening processes will be conducted using software
called “Rayyan” - a free webtool designed to help re-
searchers working on systematic reviews [24]. The re-
sults of all the searches will be imported into the
software and duplicates will be removed. After that, two
authors will carry out the screening independently (title,
abstract and full-text) using the software and the dis-
agreements will be resolved through discussion.
Data extraction
A standardised data extraction form will be designed for
the extraction of the information of interest from each
study. Two authors will independently extract the data
from the selected articles and all disagreements will be
resolved by discussion. We will extract the following var-
iables from the identified studies: province, study year(s),
sample size, number of cases, prevalence, 95% CI, age
range, percentage of male or female participants in the
sample, method of ascertainment, the diagnostic guide-
line or case definition used and the proportion of poten-
tially eligible people.
Critical appraisal of identified studies
We will critically appraise all the included studies using
a tool developed by Munn et al. [25] for the
methodological guidance for systematic reviews of ob-
servational epidemiological studies reporting prevalence
and incidence data. The tool consists of nine criteria:
1. Was the sample frame appropriate to address the
target population?
2. Were study participants sampled appropriately?
3. Was the sample size adequate?
4. Were the study subjects and the setting described
in detail?
5. Was the data analysis conducted with sufficient
coverage of the identified sample?
6. Were valid methods used for the identification of
the condition?
7. Was the condition measured in a standard, reliable
way for all participants?
8. Was there appropriate statistical analysis?
9. Was the response rate adequate, and if not, was the
low response rate managed appropriately?
In addition, the certainty of the evidence will be
assessed using the Grading of Recommendations, As-
sessment, Development and Evaluations (GRADE) tool
[26]. The following domains of GRADE will be assessed:
risk of bias, imprecision, inconsistency, indirectness and
publication bias. The overall strength of evidence of the
outcome of interest will be reported. The levels of qual-
ity of evidence will be placed into one of the four cat-
egories: very low, low, moderate and high. Two authors
will independently appraise all the included studies and
disagreements will be resolved by discussion.
Meta-analyses
To estimate the pooled prevalence of FASD in South
Africa, we will conduct a meta-analysis assuming the
presence of heterogeneity a priori and use a random-
effects model to analyse the results. We will trans-
form the data using the Freeman-Tukey double arc-
sine transformation to prevent the overweighting of
studies reporting extremely low prevalence. We will
assess heterogeneity between prevalence estimates
using the Cochrane Q test and the I2 statistic. We
will assess publication bias by (1) visually inspecting
the funnel plot for a skewed distribution; (2) by using
a ranked correlation test and (3) a weighted regres-
sion test. We will access publication bias (if it is
present because it is unlikely in the case of prevalence
studies) by the inspection of Funnel plots.
Individual and pooled estimates from all meta-analyses
will be presented using tables, and forest plots will be
created. Statistical heterogeneity will be measured and
evaluated using forest plots and calculations of
Cochran’s chi-square test and the I2 statistic during
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meta-analyses, and guidance from the Cochrane Hand-
book will be used to interpret heterogeneity.
A narrative synthesis will be used if meta-analysis is
not suitable.
Discussions
In South Africa, several studies have reported a lack of
specific policies for the prevention and management of
FASD [27–31]. However, clauses that could be attributed
to the prevention and management of FASD exist in
other related policy documents [21]. Also, a review has
reported the scant prevention and management inter-
ventions for FASD in South Africa [32]. The lack of a
specific policy and the scanty existence of interventions
for FASD could be because there are several public
health issues demanding policy attention and interven-
tions. Because of limited resources, the government will
need to set priorities for public health policy, funding for
public health initiatives and healthcare planning. There-
fore, the government needs research-based evidence on
each issue to plan intervention strategies.
Ethics and dissemination
This study (protocol) does not require ethical clearance.
It does not involve participants, therefore, there are no
rights or privacy to protect. According to the PRISMA
statement and checklist, the study will involve searching
for the published papers and analysing their outcomes.
After the completion of both the protocol and the re-
view, they will be published in peer-reviewed journals to
disseminate the findings widely. Also, the findings will
be shared in non-peer review platforms such as the con-
versation and online newspapers (News24, Daily Maver-
ick and Mail and Guardian).
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